Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Baxalta Gmbh patents

Recent patent applications related to Baxalta Gmbh. Baxalta Gmbh is listed as an Agent/Assignee. Note: Baxalta Gmbh may have other listings under different names/spellings. We're not affiliated with Baxalta Gmbh, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Baxalta Gmbh-related inventors




Date Baxalta Gmbh patents (updated weekly) - BOOKMARK this page
10/05/17Non-anticoagulant sulfated or sulfonated synthetic polymers
09/21/17Fviii peptides for immune tolerance induction and immunodiagnostics
09/21/17Animal protein-free media for cultivation of cells
09/14/17Virus filtration of cell culture media
08/24/17Nucleophilic catalysts for oxime linkage
08/24/17Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives
08/17/17Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a
08/10/17Subcutaneous administration of adamts13
08/10/17Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a
08/10/17Recombinant co-expression of vitamin k epoxide reductase subunit 1 to improve vitamin k dependent protein expression
08/10/17Method and compositions for specifically detecting physiologically acceptable polymer molecules
08/03/17Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
07/27/17Characterization of cho-mif gene and protein, and use thereof
07/13/17Models of thrombotic thrombocytopenic purpura and methods of use thereof
06/22/17Biologically active peptides
06/22/17Tfpi inhibitors and methods of use
06/15/17Subcutaneous infusion device for injecting medicinal substances
06/08/17Tfpi inhibitors and methods of use
06/08/17Factor viii polymer conjugates
06/01/17Methods of measuring adamts 13 activity
06/01/17Methods for treating bleeding disorders using a platelet subpopulation
05/11/17Packaging unit for single medical device
05/04/17Method of administering porcine b-domainless fviii
04/27/17Stabilized liquid and lyophilized adamts13 formulations
03/30/17Stirred tank reactor systems and methods of use
03/09/17Composition exhibiting a von willebrand factor (vwf) protease activity comprising a polypeptide chain with the amino acid sequence aaggilhlellv
02/23/17Combination therapy of anti-mif antibodies and chemotherapeutics
02/23/17Cell culture medium for adamts protein expression
02/16/17Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
02/09/17Peptides and methods of use
01/26/17Pooling device for single or multiple medical containers
01/12/17Method of producing recombinant high molecular weight vwf in cell culture
01/05/17Novel albumin-free factor viii formulations
12/29/16Stabilized liquid and lyophilized adamts13 formulations
12/15/16Blood coagulation protein conjugates
11/17/16Anti-mif immunohistochemistry
11/10/16A predicting a performance characteristic of a plant or yeast hydrolysate and its use
10/27/16Removal of serine proteases by treatment with finely divided silicon dioxide
08/25/16Cell culture processes
08/25/16Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
08/18/16Chimeric ospa genes, proteins and methods of use thereof
07/14/16Modified blood factors comprising a low degree of water soluble polymer
07/14/16Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease
06/30/16Treatment of coagulation disease by administration of recombinant vwf
06/02/16Method of inhibiting binding or activity of mif by administering a mif antagonist
05/12/16Lyophilized recombinant vwf formulations
05/12/16Factor viia-polysialic acid conjugates having prolonged in vivo half-life
05/05/16Blood coagulation protein conjugates
04/28/16Methods for treating bleeding disorders using a platelet subpopulation
03/24/16Animal protein-free media for cultivation of cells
03/10/16Oligopeptide-free cell culture media
03/03/16Factor viii polymer conjugates
03/03/16Biologically active peptides
02/18/16Factor x activation
02/18/16Production of fully processed and functional factor x in a furin-secreting mammalian expression system
02/11/16Purification vitamin k dependent proteins by anion exchange chromatography
12/10/15Variant of antihemophilic factor viii having increased specific activity
11/19/15Cell culture medium for adamts protein expression
09/10/15Method of enhancing cell growth using alkyl-amine-n-oxide (aanox)







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Baxalta Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Baxalta Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';